Anti-interleukin-2 receptor (IL-2R) antibody against rejection of organ grafts.
Kupiec-Weglinski
J W
JW
Harvard Medical School, Department of Surgery, Brigham and Women's Hospital, Boston, Ma.
Padberg
W
W
Uhteg
L C
LC
Towpik
E
E
Lord
R H
RH
Ma
L
L
Diamantstein
T
T
Strom
T B
TB
Tilney
N L
NL
D000818:Animals; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D006084:Graft Rejection / Q000276:immunology; D016027:Heart Transplantation / Q000276:immunology; D007165:Immunosuppression Therapy; D007376:Interleukin-2 / Q000096:biosynthesis; D007377:Interleukin-3 / Q000096:biosynthesis; D051379:Mice; D051381:Rats; D011919:Rats, Inbred Strains; D015375:Receptors, Interleukin-2 / Q000276:immunology*; D006377:T-Lymphocytes, Helper-Inducer / Q000276:immunology; D050378:T-Lymphocytes, Regulatory / Q000276:immunology; D014184:Transplantation, Homologous
D000911:Antibodies, Monoclonal; D007376:Interleukin-2; D007377:Interleukin-3; D015375:Receptors, Interleukin-2